January
सोमंबुगुशुशनिर
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
February
सोमंबुगुशुशनिर
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
March
सोमंबुगुशुशनिर
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
April
सोमंबुगुशुशनिर
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
May
सोमंबुगुशुशनिर
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
June
सोमंबुगुशुशनिर
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
July
सोमंबुगुशुशनिर
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
August
सोमंबुगुशुशनिर
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
September
सोमंबुगुशुशनिर
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
October
सोमंबुगुशुशनिर
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
November
सोमंबुगुशुशनिर
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
December
सोमंबुगुशुशनिर
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
घटना घनत्व:
1-5
6-9
10-12
13+
2023 में घटनाएँ
—
2023: First CRISPR Gene Therapy Approved (Casgevy) (2023)
Landmark Approval
Casgevy's approval realised the clinical potential of [[term:crispr-drug-discovery|CRISPR]]-Cas9 gene editing in human patients, demonstrating durable functional cure of two severe …
—
2023: Lecanemab: First Clearly Effective Amyloid Drug (2023)
Landmark Approval
Lecanemab became the first Alzheimer's therapy to demonstrate both amyloid [[term:clearance|clearance]] and statistically significant slowing of clinical decline in a …